Cost-Effectiveness Analysis of Perioperative Oral Management after Cancer Surgery and an Examination of the Reduction in Medical Costs Thereafter: A Multicenter Study.

Administration, Oral Cost-Benefit Analysis Health Care Costs Humans Neoplasms Pneumonia / epidemiology
cancer surgery effect of reducing healthcare cost incidence of postoperative pneumonia incremental cost-effectiveness ratio oral care perioperative oral management

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
13 07 2021
Historique:
received: 22 05 2021
revised: 23 06 2021
accepted: 07 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 12 8 2021
Statut: epublish

Résumé

In April 2012, perioperative oral management (POM) was approved for inclusion in the national health insurance system of Japan to prevent the occurrence of pneumonia, a major complication in cancer patients. The subsequent decrease in the incidence of postoperative pneumonia indicated the prophylactic effect of POM. The constant increase in health expenditure necessitates a cost-effectiveness analysis. In addition, the effect of reducing healthcare costs owing to health technologies must be evaluated. In the present multi-institutional study, the cost-effectiveness analysis of POM was conducted by comparing the incidence of postoperative pneumonia and the healthcare costs between patients who received surgery for malignant tumors before (

Identifiants

DOI: 10.3390/ijerph18147453 PMID: 34299904 PMC: PMC8304623
pubmed: 34299904
pii: ijerph18147453
doi: 10.3390/ijerph18147453
pmc: PMC8304623
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Br J Surg. 2018 Nov;105(12):1688-1696
pubmed: 30088267
Lancet. 1999 Aug 7;354(9177):515
pubmed: 10465203
Support Care Cancer. 2020 Sep;28(9):4155-4162
pubmed: 31897780
Cochrane Database Syst Rev. 2016 Oct 25;10:CD008367
pubmed: 27778318
Cost Eff Resour Alloc. 2013 Sep 01;11:22
pubmed: 24128004
Can Respir J. 2016;2016:6019416
pubmed: 27445554
Clin Exp Dent Res. 2020 Apr;6(2):165-173
pubmed: 32250567
Surgery. 2010 Apr;147(4):497-502
pubmed: 20004439
J Am Geriatr Soc. 2008 Mar;56(3):577-9
pubmed: 18315680
Int J Environ Res Public Health. 2021 Jun 10;18(12):
pubmed: 34200726
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487

Auteurs

Hideki Sekiya (H)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.

Yasuhiro Kurasawa (Y)

Department of Oral & Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo 113-0034, Japan.

Yutaka Maruoka (Y)

Department of Oral & Maxillofacial Surgery, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, Japan.

Hitoshi Mukohyama (H)

Department of Oral & Maxillofacial Surgery, Yokohama City Minato Redcross Hospital, Yokohama 231-8682, Japan.

Akihide Negishi (A)

Department of Oral & Maxillofacial Surgery, National Hospital Organization Yokohama Medical Center, Yokohama 245-8575, Japan.

Shiro Shigematsu (S)

Department of Oral & Maxillofacial Surgery, Tokyo Metropolitan Tama Medical Center, Tokyo 183-8524, Japan.
ORCID: 0000-0001-6249-0058

Junpei Sugizaki (J)

Department of Dentistry, Toranomon Hospital, Tokyo 105-8470, Japan.

Masaru Ohashi (M)

Department of Oral & Maxillofacial Surgery, Japan Community Health Care Organization Tokyo Takanawa Hospital, Tokyo 108-8606, Japan.

Shiro Hasegawa (S)

Department of Dentistry & Oral Surgery, Tokyo Metropolitan Health and Hospitals Corporation, Ebara Hospital, Tokyo 145-0065, Japan.

Yutaka Kobayashi (Y)

Department of Oral & Maxillofacial Surgery, Tokyo Metropolitan Hiroo General Hospital, Tokyo 150-0013, Japan.

Masayuki Ueno (M)

Department of Health Science, Saitama Prefectural University, Saitama 343-8540, Japan.

Yukihiro Michiwaki (Y)

Department of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Department of Oral & Maxillofacial Surgery, Musashino Redcross Hospital, Tokyo 180-8610, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Administration par voie orale › Cost-Effectiveness Analysis of Perioperative...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › Cost-Effectiveness Analysis of Perioperative...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Coûts des soins de santé › Cost-Effectiveness Analysis of Perioperative...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cost-Effectiveness Analysis of Perioperative...
questionsmedicales.fr › Tumeurs › Cost-Effectiveness Analysis of Perioperative...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Cost-Effectiveness Analysis of Perioperative...